-
1
-
-
0029066299
-
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
-
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
-
(1995)
JAMA
, vol.274
, pp. 1049-1057
-
-
Boushey, C.J.1
Beresford, S.A.2
Omenn, G.S.3
Motulsky, A.G.4
-
2
-
-
0031964467
-
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study
-
Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-138.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 133-138
-
-
Hoogeveen, E.K.1
Kostense, P.J.2
Beks, P.J.3
-
3
-
-
0031841522
-
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease?
-
Chico A, Perez A, Cordoba A, et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998;41:684-693.
-
(1998)
Diabetologia
, vol.41
, pp. 684-693
-
-
Chico, A.1
Perez, A.2
Cordoba, A.3
-
4
-
-
0033647409
-
Hyperhomocysteinemia in type 2 diabetes: Relationship to macroangiopathy, nephropathy, and insulin resistance
-
Buysschaert M, Dramais AS, Wallemacq PE, et al. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000;23:1816-1822.
-
(2000)
Diabetes Care
, vol.23
, pp. 1816-1822
-
-
Buysschaert, M.1
Dramais, A.S.2
Wallemacq, P.E.3
-
5
-
-
0037898378
-
Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes
-
Looker HC, Fagot-Campagna A, Gunter EW, et al. Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes. Diabetologia 2003;46:766-772.
-
(2003)
Diabetologia
, vol.46
, pp. 766-772
-
-
Looker, H.C.1
Fagot-Campagna, A.2
Gunter, E.W.3
-
6
-
-
0034706418
-
Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: The Hoorn study
-
Hoogeveen EK, Kostense PJ, Eysink PE, et al. Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn study. Arch Intern Med 2000;160:2984-2990.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2984-2990
-
-
Hoogeveen, E.K.1
Kostense, P.J.2
Eysink, P.E.3
-
7
-
-
0033942052
-
Plasma homocysteine and its determinants in diabetic retinopathy
-
Vaccaro O, Perna AF, Mancini FP, et al. Plasma homocysteine and its determinants in diabetic retinopathy. Diabetes Care 2000;23:1026-1027.
-
(2000)
Diabetes Care
, vol.23
, pp. 1026-1027
-
-
Vaccaro, O.1
Perna, A.F.2
Mancini, F.P.3
-
8
-
-
0034573061
-
Plasma homocysteine and microvascular complications in type 1 diabetes
-
Vaccaro O, Perna AF, Mancini FP, et al. Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis 2000;10:297-304.
-
(2000)
Nutr Metab Cardiovasc Dis
, vol.10
, pp. 297-304
-
-
Vaccaro, O.1
Perna, A.F.2
Mancini, F.P.3
-
9
-
-
0030923631
-
Hyperhomocysteinaemia and end stage renal disease
-
Gupta A, Robinson K. Hyperhomocysteinaemia and end stage renal disease. J Nephrol 1997;10:77-84.
-
(1997)
J Nephrol
, vol.10
, pp. 77-84
-
-
Gupta, A.1
Robinson, K.2
-
10
-
-
37449000321
-
Circulating homocysteine levels in patients with type 2 diabetes mellitus
-
Ndrepepa G, Kastrati A, Braun, et al. Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:66-73.
-
(2008)
Nutr Metab Cardiovasc Dis
, vol.18
, pp. 66-73
-
-
Ndrepepa, G.1
Kastrati, A.2
Braun3
-
11
-
-
23244456667
-
Homocysteine in microvascular endothelial cell barrier permeability
-
Tyagi SC, Lominadze D, Roberts AM. Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem Biophys 2005;43:37-44.
-
(2005)
Cell Biochem Biophys
, vol.43
, pp. 37-44
-
-
Tyagi, S.C.1
Lominadze, D.2
Roberts, A.M.3
-
12
-
-
0030610589
-
Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine
-
Wang H, Yoshizumi M, Lai K, et al. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 1997;272:25380-25385.
-
(1997)
J Biol Chem
, vol.272
, pp. 25380-25385
-
-
Wang, H.1
Yoshizumi, M.2
Lai, K.3
-
13
-
-
0030015522
-
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
-
Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 1996;98:24-29.
-
(1996)
J Clin Invest
, vol.98
, pp. 24-29
-
-
Lentz, S.R.1
Sobey, C.G.2
Piegors, D.J.3
-
14
-
-
0030188563
-
The oxidant stress of hyperhomocyst13(e)inemia
-
Loscalzo J. The oxidant stress of hyperhomocyst13(e)inemia. J Clin Invest 1996;98:5-7.
-
(1996)
J Clin Invest
, vol.98
, pp. 5-7
-
-
Loscalzo, J.1
-
15
-
-
0346099260
-
Association of neovascular age-related macular degeneration and hyperhomocysteinemia
-
Axer-Siegel R, Bourla D, Ehrlich R, et al. Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol 2004;137:84-89.
-
(2004)
Am J Ophthalmol
, vol.137
, pp. 84-89
-
-
Axer-Siegel, R.1
Bourla, D.2
Ehrlich, R.3
-
16
-
-
33646807420
-
Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration
-
Kamburoglu G, Gumus K, Kadayifcilar S, et al. Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2006;244:565-569.
-
(2006)
Graefes Arch Clin Exp Ophthalmol
, vol.244
, pp. 565-569
-
-
Kamburoglu, G.1
Gumus, K.2
Kadayifcilar, S.3
-
17
-
-
2442572249
-
Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4
-
Roybal CN, Yang S, Sun CW, et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 2004;279:14844- 14852.
-
(2004)
J Biol Chem
, vol.279
, pp. 14844-14852
-
-
Roybal, C.N.1
Yang, S.2
Sun, C.W.3
-
18
-
-
34347380194
-
Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina
-
Lee I, Lee H, Kim JM, et al. Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci Biotechnol Biochem 2007;71:1203-1210.
-
(2007)
Biosci Biotechnol Biochem
, vol.71
, pp. 1203-1210
-
-
Lee, I.1
Lee, H.2
Kim, J.M.3
|